Publications by Axel Berg-Larsen
9 publications found
Original articles
Tumor growth inhibition and immune system activation following treatment with thorium-227 conjugates and PD-1 check-point inhibition in the MC-38 murine model
Front Med (Lausanne), 9, 1033303
DOI 10.3389/fmed.2022.1033303, PubMed 36457578
Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy
J Immunother Cancer, 9 (10)
DOI 10.1136/jitc-2021-002387, PubMed 34615703
Induction of the BIM Short Splice Variant Sensitizes Proliferating NK Cells to IL-15 Withdrawal
J Immunol, 202 (3), 736-746
DOI 10.4049/jimmunol.1801146, PubMed 30578306
Spatiotemporal Resolution of Rab9 and CI-MPR Dynamics in the Endocytic Pathway
Traffic, 17 (3), 211-29
DOI 10.1111/tra.12357, PubMed 26663757
The human-specific invariant chain isoform Iip35 modulates Iip33 trafficking and function
Immunol Cell Biol, 92 (9), 791-8
DOI 10.1038/icb.2014.54, PubMed 24983457
Differential regulation of Rab GTPase expression in monocyte-derived dendritic cells upon lipopolysaccharide activation: a correlation to maturation-dependent functional properties
PLoS One, 8 (9), e73538
DOI 10.1371/journal.pone.0073538, PubMed 24039975
Differential regulation of MHC II and invariant chain expression during maturation of monocyte-derived dendritic cells
J Leukoc Biol, 91 (5), 729-37
DOI 10.1189/jlb.0311150, PubMed 22371435
Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation
Nat Immunol, 10 (10), 1096-101
DOI 10.1038/ni.1780, PubMed 19718029
Theses
Polymorphic residues of HLA-DQ2.2 and HLA-DQ2.5 that affect CLIP presentation and stability
A. Berg-Larsen, Oslo, 71 s.
BIBSYS 093504535